PIRS Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 6.39%
Insider Buying (Last 12 Months): $92,311.00
Insider Selling (Last 12 Months): $0.00
Pieris Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at Pieris Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Pieris Pharmaceuticals Share Price & Price History
Current Price: $13.60
Price Change: +0.30 (1.20%)
As of 12/13/2024 01:00 AM ET
Pieris Pharmaceuticals Insider Trading History
SEC Filings (Institutional Ownership Changes) for Pieris Pharmaceuticals (NASDAQ:PIRS)
40.11% of Pieris Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at PIRS by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
Pieris Pharmaceuticals Institutional Trading History
Data available starting January 2016
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.
Read More on Pieris Pharmaceuticals
Today's Range
Now: $13.60
52 Week Range
Now: $13.60
Volume
51,728 shs
Average Volume
60,946 shs
Market Capitalization
$17.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.61
Who are the company insiders with the largest holdings of Pieris Pharmaceuticals?